<?xml version="1.0" encoding="UTF-8"?>
<ref id="B29">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kloss</surname>
    <given-names>C. C.</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Melenhorst</surname>
    <given-names>J. J.</given-names>
   </name>
   <name>
    <surname>Lacey</surname>
    <given-names>S. F.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2018</year>). 
  <article-title>Dominant-Negative TGF-β receptor enhances PSMA-Targeted human CAR T cell proliferation and augments prostate cancer eradication.</article-title>
  <source>
   <italic>Mol. Ther.</italic>
  </source>
  <volume>26</volume>
  <fpage>1855</fpage>–
  <lpage>1866</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.ymthe.2018.05.003</pub-id>
  <?supplied-pmid 29807781?>
  <pub-id pub-id-type="pmid">29807781</pub-id>
 </mixed-citation>
</ref>
